Login / Signup

Feasibility of a Smartphone Application for Education and Symptom Management of Patients With Renal Cell Carcinoma on Combined Tyrosine Kinase and Immune Checkpoint Inhibitors.

Gabriel Roman SouzaKea TurnerKeerthi GullapalliMahati ParavathaneniFilip IonescuAdele SemaanAmayla Budet DeJesusGillian TrujilloCasey LeYoungchul KimXiaoqi SunSarah RaymondAmy SchneiderBrandon ManleyRohit JainScott GilbertHeather S L JimPhilippe E SpiessJad Chahoud
Published in: JCO clinical cancer informatics (2024)
The mHealth application designed for education and symptom management in patients with advanced RCC undergoing combination ICI-TKI has proven to be both acceptable and feasible, meeting previous research benchmarks.
Keyphrases
  • tyrosine kinase
  • renal cell carcinoma
  • epidermal growth factor receptor
  • healthcare
  • quality improvement
  • advanced non small cell lung cancer